特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の核医学・放射性医薬品市場:タイプ、用途、医療処置件数、および地域別の予測

Global Nuclear Medicine/ Radiopharmaceuticals Market Size study, by Type, Application, by Procedural Volume and Regional Forecasts 2019-2026

発行 Bizwit Research & Consulting LLP 商品コード 925835
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.99円で換算しております。
世界の核医学・放射性医薬品市場:タイプ、用途、医療処置件数、および地域別の予測 Global Nuclear Medicine/ Radiopharmaceuticals Market Size study, by Type, Application, by Procedural Volume and Regional Forecasts 2019-2026
出版日: 2020年02月04日 ページ情報: 英文
概要

当レポートは世界の核医学・放射性医薬品市場について調査しており、市場成長要因、機会や課題、タイプ・用途・医療処置件数・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

第1章 エグゼクティブサマリー

  • 市場のスナップショット
  • 市場推計および予測:世界/セグメント別
  • 主な動向
  • 推計方法
  • 調査の前提条件

第2章 市場定義および範囲

  • 調査の目的
  • 市場定義・範囲
    • 調査範囲
    • 産業の進展
  • 調査のために考慮された年
  • 為替レート

第3章 市場力学

  • 市場影響分析
    • 市場成長要因
    • 市場の課題
    • 市場機会

第4章 産業分析

  • ポーターのファイブフォース分析
  • PEST分析
  • 投資採用モデル
  • アナリストの提言・結論

第5章 市場分析:タイプ別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場推計・予測
  • サブセグメント分析
    • 核医学診断
    • 放射性医薬品

第6章 市場分析:用途別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場推計・予測
  • サブセグメント分析
    • 診断
    • 治療

第7章 市場分析:医療処置件数別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場推計・予測
  • サブセグメント分析
    • 診断
    • 治療

第8章 市場分析:地域別

  • 市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他

第9章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • Cardinal Health
    • GE Healthcare
    • Curium
    • Lantheus Medical Imaging
    • Bayer
    • Bracco Imaging
    • Eczacibasi-Monrol Nuclear Products
    • Nordion
    • Advanced Accelerator Applications
    • Positron Corporation

第10章 調査方法

  • 調査方法
    • データマイニング
    • 分析
    • 市場予測
    • 検証
    • 出版
  • 調査属性
  • 調査の前提条件
図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET
  • TABLE 3. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY PROCEDURAL VOLUME 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 23. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 26. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 32. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 54. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, COMPANY MARKET SHARE ANALYSIS (2018)
目次

Global Nuclear Medicine/ Radiopharmaceuticals Market is valued approximately at USD 3.95 Billion in 2018 and is anticipated to grow with a growth rate of more than 5.90% over the forecast period 2019-2026. Nuclear medicine is medical specialty that uses radioactive tracers (radiopharmaceutical) to determine bodily function and to diagnose and treat disease. It is featured with designed camera that allows doctor to track the path of these radioactive trackers. In nuclear medication, Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) are common imaging scanning those are widely used in end-use industry. Nuclear medicine is implemented in human body by injecting radioactive material (radiopharmaceuticals or radiotracers) that can easily be detected on the PET scan. Radiotracers are commonly used in cancer treatment as it contains fluorodeoxyglucose that is a molecule like glucose. Cancer cells are metabolically active and absorb glucose at a higher speed that can easily be detected by PET scans. Therefore, efficient application of Nuclear medicine in cancer detection coupled with rising cancer cases across the globe accelerate the growth of market over the forecast years. For instance: According to the International Agency for Research on Cancer (IARC) 2018, over 17 Billion new cancer cases were registered in 2018. Additionally, increasing incidence and prevalence of target conditioning is the factor driving the growth of market over the upcoming years. Whereas, application of radiopharmaceuticals in neurological disorders is an opportunity for the market growth. However, short life of radiopharmaceuticals are the factors hamper the growth of market over the forecast years.

The regional analysis of global Nuclear Medicine/ Radiopharmaceuticals market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America accounts for the largest share in the global Nuclear Medicine market due to the increased better infrastructure facility in the health care sector. Similarly, North America is the fastest growing region in the market owing to the effectiveness of a diagnosis procedure for the early detection such as cancer and cardiac diseases.

Market player included in this report are:

Cardinal Health

Positron Corporation

GE Healthcare

Curium

Lantheus Medical Imaging

Bayer

Bracco Imaging

Eczacibasi-Monrol Nuclear Products

Nordion

Advanced Accelerator Applications

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Diagnostic Nuclear Medicine

Therapeutic Nuclear Medicine

By Application:

Diagnostic Application

Therapeutic application

By Procedural Volume:

Diagnostic procedures

Therapeutic procedures

By Regions:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Nuclear Medicine/ Radiopharmaceuticals Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
    • 1.2.1. Nuclear Medicine/ Radiopharmaceuticals Market, by Region, 2017-2026 (USD Billion)
    • 1.2.2. Nuclear Medicine/ Radiopharmaceuticals Market, by Type ,2017-2026 (USD Billion)
    • 1.2.3. Nuclear Medicine/ Radiopharmaceuticals Market, by Application,2017-2026 (USD Billion)
    • 1.2.4. Nuclear Medicine/ Radiopharmaceuticals Market, by Procedural Volume, 2017-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Nuclear Medicine/ Radiopharmaceuticals Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Nuclear Medicine/ Radiopharmaceuticals Market Dynamics

  • 3.1. Nuclear Medicine/ Radiopharmaceuticals Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Nuclear Medicine/ Radiopharmaceuticals Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Type, Performance - Potential Analysis
  • 5.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 5.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
    • 5.4.1. Diagnostic Nuclear Medicine
    • 5.4.2. Therapeutic Nuclear Medicine

Chapter 6. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Application, Performance - Potential Analysis
  • 6.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
  • 6.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
    • 6.4.1. Diagnostic Application
    • 6.4.2. Therapeutic Application

Chapter 7. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Procedural Volume

  • 7.1. Market Snapshot
  • 7.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Procedural Volume, Performance - Potential Analysis
  • 7.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Procedural Volume 2016-2026 (USD Billion)
  • 7.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
    • 7.4.1. Diagnostic procedures
    • 7.4.2. Therapeutic procedures

Chapter 8. Global Nuclear Medicine/ Radiopharmaceuticals Market, Regional Analysis

  • 8.1. Nuclear Medicine/ Radiopharmaceuticals Market, Regional Market Snapshot
  • 8.2. North America Nuclear Medicine/ Radiopharmaceuticals Market
    • 8.2.1. U.S. Nuclear Medicine/ Radiopharmaceuticals Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 8.2.1.2. Application breakdown estimates & forecasts, 2016-2026
      • 8.2.1.3. Procedural Volume breakdown estimates & forecasts, 2016-2026
    • 8.2.2. Canada Nuclear Medicine/ Radiopharmaceuticals Market
  • 8.3. Europe Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
    • 8.3.1. U.K. Nuclear Medicine/ Radiopharmaceuticals Market
    • 8.3.2. Rest of Europe Nuclear Medicine/ Radiopharmaceuticals Market
  • 8.4. Asia-Pacific Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
    • 8.4.1. China Nuclear Medicine/ Radiopharmaceuticals Market
    • 8.4.2. India Nuclear Medicine/ Radiopharmaceuticals Market
    • 8.4.3. Japan Nuclear Medicine/ Radiopharmaceuticals Market
    • 8.4.4. Rest of Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market
  • 8.5. Latin America Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
    • 8.5.1. Brazil Nuclear Medicine/ Radiopharmaceuticals Market
    • 8.5.2. Mexico Nuclear Medicine/ Radiopharmaceuticals Market
  • 8.6. Rest of The World Nuclear Medicine/ Radiopharmaceuticals Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Cardinal Health
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. GE Healthcare
    • 9.2.3. Curium
    • 9.2.4. Lantheus Medical Imaging
    • 9.2.5. Bayer
    • 9.2.6. Bracco Imaging
    • 9.2.7. Eczacibasi-Monrol Nuclear Products
    • 9.2.8. Nordion
    • 9.2.9. Advanced Accelerator Applications
    • 9.2.10. Positron Corporation

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption